ArticleAmerican health & drug benefits2018

Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis After a Change in Targeted Therapy.

Machaon M K Bonafede et al.PubMed ↗Full text ↗

No numbers read from the abstract.